Avoiding exploitation in multinational covid-19 vaccine trials.
| Autor: | Iyer AA; Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA., Millum J; Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA., Grady C; Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA., Wendler D; Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ (Clinical research ed.) [BMJ] 2021 Mar 04; Vol. 372, pp. n541. Date of Electronic Publication: 2021 Mar 04. |
| DOI: | 10.1136/bmj.n541 |
| Abstrakt: | Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have no interests to declare. The writing of this editorial was supported by NIH intramural funds but the views expressed are the authors and do not represent the positions or policies of the National Institutes of Health, the Department of Health and Human Services, or the United States Government. Provenance and peer review: Not commissioned; externally peer reviewed. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|